Tech Company Financing Transactions

Cadence Neuroscience Funding Round

Lumira Ventures, Angelini Ventures and F-Prime Capital participated in a $26 million Series B funding round for Cadence Neuroscience. The funding round was announced on 5/17/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

2036 223rd Pl. NE
Sammamish, WA 98074
USA

Phone

(425) 681-6863

Website

www.cadenceneuro.com

Email Address

Not Recorded

Overview

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy. Our core technology has been developed at Mayo Clinic and is under clinical evaluation.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kent Leyde

        

Chief Scientific Officer

Douglas Sheffield

        

Browse more venture capital transactions:

Prev: 5/17/2023: Stacklok venture capital transaction
Next: 5/17/2023: ClearCam venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary